Photorefractive keratectomy for myopia in the setting of adenoviral subepithelial infiltrates.
OBJECTIVE
To report a patient with persistent subepithelial corneal opacities 18 months after adenoviral keratoconjunctivitis who underwent photorefractive keratectomy for the correction of myopia.


METHODS
Case report, review of medical literature, and slit-lamp photography.


RESULTS
The patient underwent photorefractive keratectomy in each eye, 1 week apart, with ablation of central corneal opacities and resultant best-corrected visual acuity of BE, 20/20. Symptomatic subepithelial stromal infiltrates recurred in the peripheral but not the central cornea of each eye 3 months after laser treatment.


CONCLUSIONS
Photorefractive keratectomy was successful in the correction of myopia and prevented the recurrence of adenoviral subepithelial corneal infiltrates within the laser-treated central cornea.
Fite
S W
SW
Molecular Pathogenesis of Eye Infection Research Center, Dean A. McGee Eye Institute, Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Chodosh
J
J
D000258:Adenovirus Infections, Human / Q000188:drug therapy / Q000601:surgery* / Q000821:virology; D000260:Adenoviruses, Human; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003315:Cornea / Q000601:surgery* / Q000821:virology; D003318:Corneal Opacity / Q000188:drug therapy / Q000601:surgery / Q000821:virology; D004848:Epithelium / Q000821:virology; D015828:Eye Infections, Viral / Q000188:drug therapy / Q000601:surgery* / Q000821:virology; D006801:Humans; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000601:surgery* / Q000821:virology; D054018:Lasers, Excimer; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000601:surgery*; D018903:Photorefractive Keratectomy; D013256:Steroids; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013256:Steroids